New Jersey Supreme Court Cites Higher Evidence Standard in Pharma Case

  • Home >
  • Resources >
  • New Jersey Supreme Court Cites Higher Evidence Standard in Pharma Case
August 02, 2018

A unanimous decision from the New Jersey Supreme Court suggested that the state’s courts will now adhere to Daubert evidence standards, Legal Newsline reports in Forbes.

Justice Jaynee LaVecchia said a lawsuit that tried to link the drug Accutane to Crohn’s Disease “flies in the face of consistent findings of no causal association as determined by higher levels of scientific proof,” and cited the Daubert case throughout the opinion. The Daubert standard uses a heightened level of scrutiny for expert evidence in court, which LaVecchia said will “aid our trial courts in their role as the gatekeeper of scientific expert testimony in civil cases.”